Caplin Point Laboratories informs about press release

20 Sep 2023 Evaluate

Caplin Point Laboratories has informed that it enclosed a Press Release regarding grant of final approval by the United States Food and Drug Administration (USFDA) for the Abbreviated New Drug Application (ANDA) Norepinephrine Bitartrate Injection USP, to its Subsidiary Caplin Steriles.

The above information is a part of company’s filings submitted to BSE.

Caplin Point Lab Share Price

2553.20 43.20 (1.72%)
07-Jan-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1854.15
Dr. Reddys Lab 1350.75
Cipla 1497.80
Lupin 2357.65
Zydus Lifesciences 1001.20
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.